2015, Number 2
<< Back Next >>
Rev Cub Oftal 2015; 28 (2)
Treatment of paralytic strabismus with botulinum toxin A
Cáceres TM, Márquez FM, Cáceres TO, Hidalgo CT, Ferrás BY, Zazo ER
Language: Spanish
References: 24
Page: 168-176
PDF size: 97.40 Kb.
ABSTRACT
Objectives: to assess the results of the use of botulinum toxin A in correcting
paralytic strabismus and to identify those associated factors that have an impact on
the therapeutic response.
Methods: a descriptive study of a series of 93 cases with paralytic strabismus which
were treated with botulinum toxin A.
Results: fifty three cases were diagnosed with mild, 38 with moderate and just two
with severe strabismus. The time of progression and the clinical severity were related
factors that influence the therapeutic response.
Conclusions: botulinum toxin A is effective in most of cases. The best results are
achieved in those people with lower deviation degree and less time of progression
elapsed from the onset of strabismus to the administration of the injected medication.
REFERENCES
Eguía F, Río M, Capote A. Manual de Diagnóstico y Tratamiento en Oftalmología. La Habana: Editorial Ciencias Médicas; 2009.
Mitchell P, Parks M. Cranial Nerve Palsies. En: Duane's Ophthalmology. Duane's Clinical Ophthalmology [CD-ROM]. Philadelphia: Lippincott; 2008.
Shallo-Hoffman J, Acheson J, Bentley C, Bronstein AM. The influence of adaptation of visual motion detection in chronic sixth nerve palsy after treatment with botulinum toxin. Strabismus. 2006;14(3):129-35.
Mark AS. Oculomotor motion disorders: Current imaging of cranial nerves 3, 4 and 6. Washington: Seminars in Ultrasound CT and MRI. 1998;19(3):240-56.
Lee J. Modern management of sixth nerve palsy. J Ophthalmol. 1992;20(1):41-6
Quah BL, Ling YL, Cheong PY, Balakrishnan V. A review of 5 years experience in the use of botulinum toxin A in the treatment of sixth cranial nerve palsy at the Singapore National Eye Centre. Singapore Med J. 1999;40(6):405-9.
Bartalena L, Tanda M. Clinical practice. Graves' Ophthalmopathy. N Engl J Med. 2009;360(10):994-1001.
Cáceres M, Pérez R. Variantes terapéuticas del estrabismo restrictivo. Rev Cubana Oftalmol. 2009;22(2):8-14.
Cáceres M, Marqués M, Cáceres O. Toxina botulínica versus cirugía en el estrabismo restrictivo. Rev Cubana Oftalmol. 2010;23(1):561-7.
Scott AB. Botulinum toxin injections into extraocular muscles as an alternative to strabismus surgery. Ophthalmology. 1980;87(10):1044-9.
Kumar S, MohiuddinAraf M. Therapeutic Application of Botulinum Toxin in Clinical Practice. The Open General and Internal Medicine Journal. 2009;3:14-9.
Kaynak-Hekimhan P. Noncosmeticperiocular therapeutic applications of botulinum toxin. Middle East Afr J Ophthalmol. 2010;17(2):113-20.
Hornik A, Gruener G, Jay W. Adverse reactions from Botulinum Toxin Administration. Neuro-Ophthalmology. 2010:6-13.
Moguel-Ancheita S. Tratamiento del estrabismo con toxina botulínica. Rev Mex Pediatr. 2000;67(4):166-71.
Moguel-Ancheita S, Dixon-Olvera S, Martínez-Oropeza S, Orozco-Gomez LP. Utilidad de la toxina botulínica en el tratamiento del estrabismo en enfermedades sistémicas. Arch Soc Esp Oftalmol. 2003;78(1):9-14.
Minguini NM, de Carvalho K, Bosso FL, Hirata FE, Kara JN. Surgery with intraoperative botulinum toxin-A injection for the treatment of large-angle horizontal strabismus: a pilot study. Clinics. 2012;67(3):279-82.
Prieto Díaz J, Souza Dias C. Estrabismo. Buenos Aires: Editorial Científica Argentina; 2005.
Rowe F, Noonan C. Toxina botulínica para el tratamiento del estrabismo. Biblioteca Cochrane Plus. 2009 [citado 20 de dici8embre de 2013]. Disponible en: http://www.update-sofwere.com
Cooper K, Lee JP, MacEwen C, Jones S. Botulinum toxin A injection for acute sixth nerve palsy. Transactions of the 8th International Orthoptic Congress 1991;8:336-40.
Sanjari MS, Falavarjani KG, Kashkouli MB, Aghai GH, Nojomi M, Rostami H. Botulinum toxin injection with and without electromyographic assistance for treatment of abducens nerve palsy: a pilot study. J AAPOS. 2008;12(3):259-62.
Tavakolizadeh S, Farahi A. Presence of Fusion in Albinism after Strabismus Surgery Augmented with Botulinum Toxin (Type A) Injection. Korean J Ophthalmol. 2013;27(4):308-10.
Caleo M, Antonucci F, Restani L, Mazzocchio R. A reappraisal of the central effects of botulinum neurotoxin type A: by what mechanism? J Neurochem. 2009;109(1):15-24.
Mauricio J, Lozano V. Uso de la toxina botulínica en el estrabismo. Rev Franj Ocul. 2003;4(24):16-8.
Kikkawa DO, Cruz RC Jr, Christian WK, Rikkers S, Weinreb RN, Levi L, et al. Botulinum A toxin injection for restrictive myopathy of Thyroid-related Orbitopathy: Effect on intraocular pressure. Am J Ophthalmol. 2003;135(4):427-31.